5,045 reports of this reaction
2.1% of all PSEUDOEPHEDRINE HCL reports
#5 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #5 most commonly reported adverse reaction for PSEUDOEPHEDRINE HCL, manufactured by Major Pharmaceuticals. There are 5,045 FDA adverse event reports linking PSEUDOEPHEDRINE HCL to RHEUMATOID ARTHRITIS. This represents approximately 2.1% of all 242,486 adverse event reports for this drug.
Patients taking PSEUDOEPHEDRINE HCL who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is a less commonly reported adverse event for PSEUDOEPHEDRINE HCL, but still significant enough to appear in the safety profile.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for PSEUDOEPHEDRINE HCL:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 5,045 FDA reports for PSEUDOEPHEDRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 2.1% of all adverse event reports for PSEUDOEPHEDRINE HCL, making it a notable side effect.
If you experience rheumatoid arthritis while taking PSEUDOEPHEDRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.